Raras
Buscar doenças, sintomas, genes...
Defeito no transporte lisossomal
ORPHA:79207DOENÇA RARA

A sialina, também conhecida como cotransportador H(+)/nitrato e cotransportador H(+)/ácido siálico, é uma proteína que em humanos é codificada pelo gene SLC17A5.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por defeitos no transporte de aminoácidos para os lisossomos, levando a sintomas como diabetes insipidus nefrogênico, osteomalácia e hipofosfatemia. Afeta múltiplos sistemas e está associada a mutações nos genes CTNS, SLC17A5 e GNE.

Medicamentos
1 registrados
ELX-02

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
ELX-02
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
22 sintomas
🧠
Neurológico
18 sintomas
📏
Crescimento
17 sintomas
🦴
Ossos e articulações
15 sintomas
👁️
Olhos
14 sintomas
🫃
Digestivo
12 sintomas

+ 79 sintomas em outras categorias

Características mais comuns

Diabetes insipidus nefrogênico
Osteomalácia
Escoliose
Calvária espessada
Colelitíase
Hipofosfatemia
212sintomas
Sem dados (212)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 212 características clínicas mais associadas, ordenadas por frequência.

Diabetes insipidus nefrogênicoNephrogenic diabetes insipidus
OsteomaláciaOsteomalacia
EscolioseScoliosis
Calvária espessadaThickened calvaria
ColelitíaseCholelithiasis

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa6
Últimos 10 anos200publicações
Pico202141 papers
Linha do tempo
20202020Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição.

CTNSCystinosinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Cystine/H(+) symporter that mediates export of cystine, the oxidized dimer of cysteine, from lysosomes (PubMed:11689434, PubMed:15128704, PubMed:18337546, PubMed:22232659, PubMed:29467429, PubMed:33208952, PubMed:36113465). Plays an important role in melanin synthesis by catalyzing cystine export from melanosomes, possibly by inhibiting pheomelanin synthesis (PubMed:22649030). In addition to cystine export, also acts as a positive regulator of mTORC1 signaling in kidney proximal tubular cells, v

LOCALIZAÇÃO

Lysosome membraneMelanosome membraneCell membrane

VIAS BIOLÓGICAS (2)
Miscellaneous transport and binding eventsSLC-mediated transport of oligopeptides
MECANISMO DE DOENÇA

Cystinosis, nephropathic type

A form of cystinosis, a lysosomal storage disease due to defective transport of cystine across the lysosomal membrane. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. The classical nephropathic form has onset in the first year of life and is characterized by a polyuro-polydipsic syndrome, marked height-weight growth delay, generalized impaired proximal tubular reabsorptive capacity, with severe fluid-electrolyte balance alterations, renal failure, ocular symptoms and other systemic complications.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
48.4 TPM
Nervo tibial
37.2 TPM
Cervix Endocervix
29.4 TPM
Cervix Ectocervix
28.7 TPM
Ovário
24.3 TPM
OUTRAS DOENÇAS (4)
juvenile nephropathic cystinosisnephropathic cystinosisocular cystinosisnephropathic infantile cystinosis
HGNC:2518UniProt:O60931
SLC17A5SialinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Multifunctional anion transporter that operates via two distinct transport mechanisms, namely proton-coupled anion cotransport and membrane potential-dependent anion transport (PubMed:15510212, PubMed:21781115, PubMed:22778404, PubMed:23889254). Electroneutral proton-coupled acidic monosaccharide symporter, with a sugar to proton stoichiometry of 1:1. Exports glucuronic acid and free sialic acid derived from sialoglycoconjugate degradation out of lysosomes, driven by outwardly directed lysosomal

LOCALIZAÇÃO

Basolateral cell membraneCytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneLysosome membrane

VIAS BIOLÓGICAS (3)
Organic anion transport by SLC5/17/25 transportersSialic acid metabolismHyaluronan degradation
MECANISMO DE DOENÇA

Salla disease

Sialic acid storage disease (SASD). SASDs are autosomal recessive neurodegenerative disorders characterized by hypotonia, cerebellar ataxia and intellectual disability. They are caused by a defect in the metabolism of sialic acid which results in increased urinary excretion of unconjugated sialic acid, specifically N-acetylneuraminic acid. Enlarged lysosomes are seen on electron microscopic studies. Clinical symptoms of SD present usually at age less than 1 year and progression is slow.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
53.3 TPM
Fibroblastos
40.9 TPM
Glândula salivar
31.2 TPM
Aorta
27.6 TPM
Artéria coronária
23.4 TPM
OUTRAS DOENÇAS (3)
Salla diseasefree sialic acid storage disease, infantile formintermediate severe Salla disease
HGNC:10933UniProt:Q9NRA2
GNEBifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Bifunctional enzyme that possesses both UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities, and serves as the initiator of the biosynthetic pathway leading to the production of N-acetylneuraminic acid (NeuAc), a critical precursor in the synthesis of sialic acids. By catalyzing this pivotal and rate-limiting step in sialic acid biosynthesis, this enzyme assumes a pivotal role in governing the regulation of cell surface sialylation, playing a role in embryonic angiogene

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Sialic acid metabolism
MECANISMO DE DOENÇA

Sialuria

In sialuria, free sialic acid accumulates in the cytoplasm and gram quantities of neuraminic acid are secreted in the urine. The metabolic defect involves lack of feedback inhibition of UDP-GlcNAc 2-epimerase by CMP-Neu5Ac, resulting in constitutive overproduction of free Neu5Ac. Clinical features include variable degrees of developmental delay, coarse facial features and hepatomegaly. Sialuria inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
33.4 TPM
Glândula salivar
24.0 TPM
Cérebro - Hemisfério cerebelar
23.1 TPM
Cólon transverso
21.3 TPM
Ovário
21.0 TPM
OUTRAS DOENÇAS (4)
GNE myopathysialuriathrombocytopenia 12 with or without myopathyplatelet-type bleeding disorder 19
HGNC:23657UniProt:Q9Y223

Medicamentos e terapias

ELX-02Phase 2

Mecanismo: 80S Ribosome modulator

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

1,283 variantes patogênicas registradas no ClinVar.

🧬 CTNS: NM_004937.3(CTNS):c.329+16G>C ()
🧬 CTNS: NM_004937.3(CTNS):c.348T>G (p.Leu116=) ()
🧬 CTNS: NM_004937.3(CTNS):c.226-14A>G ()
🧬 CTNS: NM_004937.3(CTNS):c.972C>G (p.Asp324Glu) ()
🧬 CTNS: NM_004937.3(CTNS):c.971-17C>G ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Defeito no transporte lisossomal

Centros de Referência SUS

21 centros habilitados pelo SUS para Defeito no transporte lisossomal

Centros para Defeito no transporte lisossomal

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Hematopoietic Stem-Cell Gene Therapy for Cystinosis.

The New England journal of medicine2026 Feb 19

Cystinosis is a multisystemic lysosomal storage disorder caused by pathogenic variants in CTNS, the gene encoding cystinosin, a lysosomal transmembrane cystine transporter. In patients with cystinosis, cystine accumulates within lysosomes in all organs. The cystine-depleting agent cysteamine delays but does not prevent disease progression. In this phase 1-2, open-label, ongoing clinical study, we performed a preliminary assessment of CTNS-RD-04, which consists of autologous CD34+ cells transduced with lentiviral vectors carrying CTNS complementary DNA, in patients with cystinosis. The primary end points were the safety and the side-effect profiles of CTNS-RD-04. Secondary end points were measures of efficacy, including white-cell cystine levels and cystine storage depletion. Oral cysteamine was withdrawn before CTNS-RD-04 infusion, and cysteamine eyedrops were withdrawn 1 month after myeloablation. Six participants (20 to 46 years of age) received CTNS-RD-04 and were followed for 29 to 63 months. CTNS-RD-04 doses ranged from 3.63×106 to 9.59×106 CD34+ cells per kilogram of body weight, and vector copy numbers ranged from 0.59 to 2.91 copies per diploid genome. All the patients had sustained and highly polyclonal hematopoietic reconstitution; vector copy numbers at 24 months ranged from 0.51 to 2.67 copies per diploid genome. A total of 217 adverse events occurred, most of which were mild or moderate in severity and largely consistent with the procedures and underlying disease. No evidence of monoclonal expansion was noted. White-cell cystine levels decreased from baseline except in Patient 4, who had the lowest vector copy number. In this small study, CTNS-RD-04, an ex vivo gene therapy for cystinosis, had adverse effects that were largely consistent with the myeloablative regimen and underlying disease profile. White-cell cystine levels decreased after therapy. (Funded by the California Institute for Regenerative Medicine and others; ClinicalTrials.gov number, NCT03897361.).

#2

Calretinin Contributes to Trigeminal Neuropathic Pain Downstream of Cavα2δ1.

ACS chemical neuroscience2026 Feb 04

Trigeminal neuralgia is a debilitating neuropathic pain disorder characterized by facial hypersensitivity, yet its underlying molecular mechanisms remain incompletely understood. Using a mouse model of partial infraorbital nerve transection (pT-ION), we investigated transcriptomic alterations in the trigeminal ganglion (TG) to identify molecular contributors to orofacial pain. Microarray analysis identified 200 differentially expressed genes, with functional enrichment highlighting immune-related processes, calcium signaling, and lysosomal pathways. Among these, Calb2 (calretinin) emerged as a hub gene in both coexpression and protein-protein interaction networks. Immunofluorescence analysis revealed prominent colocalization of calretinin with the voltage-gated calcium channel auxiliary subunit α2δ1 (Cavα2δ1) in TG neurons. Functionally, a single perineural injection of calretinin siRNA into the trigeminal nerve significantly alleviated mechanical and cold hypersensitivity in both the maxillary and mandibular facial regions within 48 h. Pharmacological inhibition of Cavα2δ1 with gabapentin similarly attenuated pain behaviors and reduced calretinin expression in the TG. Conversely, targeted overexpression of Cavα2δ1 in naïve mice was sufficient to induce orofacial hypersensitivity and to upregulate calretinin expression in the TG. Together, these findings identify calretinin as a key downstream contributor to Cavα2δ1-associated trigeminal pain signaling and suggest that modulation of the Cavα2δ1-calretinin axis may represent a potential therapeutic strategy for trigeminal neuropathic pain.

#3

Homocysteine disrupts lysosomal function by V-ATPase inhibition.

The Journal of cell biology2026 Jan 05

Lysosomes are degradation and signaling organelles central to metabolic homeostasis. It remains unclear whether and how harmful metabolites compromise lysosome function in the etiopathology of metabolic disorders. Combining Caenorhabditiselegans and mouse models, we demonstrate that homocysteine, an intermediate in methionine-cysteine metabolism and the cause of the life-threatening disease homocystinuria, disrupts lysosomal functions. In C. elegans, mutations in cystathionine β-synthase cause strong buildup of homocysteine and developmental arrest. We reveal that homocysteine binds to and homocysteinylates V-ATPase, causing its inhibition and consequently impairment of lysosomal degradative capacity. This leads to enormous enlargement of lysosomes with extensive cargo accumulation and lysosomal membrane damage in severe cases. Cbs-deficient mice similarly accumulate homocysteine, displaying abnormal or damaged lysosomes reminiscent of lysosomal storage diseases in multiple tissues. These findings not only uncover how a metabolite can damage lysosomes but also establish lysosomal impairment as a critical contributing factor to homocystinuria and homocysteine-related diseases.

#4

N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.

The Journal of clinical investigation2026 Mar 02

N-acetyl-l-leucine (NALL), a derivative of the branched-chain amino acid leucine, has shown therapeutic potential for neurodegenerative diseases, including in prodromal stages of Parkinson's disease (PD). However, the mechanism of its protective effects has been largely unknown. Using human induced pluripotent stem cell-derived dopaminergic neurons from patients carrying GBA1, LRRK2, or VPS35 mutations, as well as from sporadic PD cases, we found that NALL treatment markedly reduced Ser129 phosphorylated α-synuclein (pS129-syn). Discovery-based proteomic analysis revealed that NALL treatment upregulated lysosomal, mitochondrial, and synaptic proteins without inducing cytotoxicity. The reduction of pS129-syn was dependent on serine protease HTRA1, which was robustly induced by NALL. Moreover, NALL increased the expression of wild-type parkin in mutant dopaminergic neurons, leading to increased glycosylated dopamine transporter, elevated synaptic membrane-associated synaptojanin-1, and accelerated synaptic vesicle endocytosis, suggesting improved synaptic function. Furthermore, in LRRK2R1441C knockin mice, NALL administration decreased pS129-syn, elevated parkin levels, and ameliorated dopamine-dependent motor learning deficits. These findings highlight the therapeutic potential of NALL for PD by its protective effects on α-synuclein pathology and synaptic function in vulnerable dopaminergic neurons.

#5

Chronic stress-induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis.

The Journal of clinical investigation2026 Feb 16

Emerging evidence demonstrates that chronic stress alters immunological, neurochemical, and endocrinological functions, thereby promoting tumor progression. However, the underlying metabolic mechanism of chronic stress in tumor progression is still elusive. Using multiomics analysis, we found that aminopeptidase N (ANPEP) was upregulated in tumors with chronic restraint, associating with the reprogramming of amino acid metabolism. Functional assays revealed that ANPEP promoted liver cancer growth and metastasis. Knockdown of ANPEP blocked chronic stress-induced liver cancer progression. Chronic stress-induced glucocorticoids promoted nuclear receptor subfamily 3 group C member 1 nuclear translocation to activate ANPEP transcription by directly binding to its promoter. Furthermore, ANPEP promotes glutathione synthesis, subsequently inhibiting ROS-induced ferroptosis. Mechanistically, ANPEP interacted with solute carrier family 3 member 2 (SLC3A2) to block membrane associated ring-CH-type finger 8-mediated lysosome-dependent degradation of SLC3A2, promoting intracellular l-cystine transport, thereby increasing glutathione synthesis. The combination of ANPEP silencing and sorafenib treatment showed a synergistic effect in inhibiting liver cancer progression. Finally, clinical data and mouse models demonstrated that chronic stress drove liver tumor progression via ANPEP-regulated SLC3A2. These findings reveal unanticipated communication between chronic stress and metabolic reprogramming during liver cancer progression, providing potential therapeutic implications for liver cancer.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.

The Journal of clinical investigation
2026

Hematopoietic Stem-Cell Gene Therapy for Cystinosis.

The New England journal of medicine
2026

Calretinin Contributes to Trigeminal Neuropathic Pain Downstream of Cavα2δ1.

ACS chemical neuroscience
2026

Chronic stress-induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis.

The Journal of clinical investigation
2025

Homology Modeling of Type-P5 ATPases from the Malaria Parasite: Insight into Their Functions and Evolution, and Implications About the Effect and Role of Intrinsically Disordered Protein Structure.

Pathogens (Basel, Switzerland)
2026

Homocysteine disrupts lysosomal function by V-ATPase inhibition.

The Journal of cell biology
2025

An Isogenic Human Myoblast Cell Model for Cystinosis Myopathy Reveals Alteration of Key Myogenic Regulatory Proteins.

Journal of cachexia, sarcopenia and muscle
2025

Hyperuricemia increases susceptibility to chronic kidney injury exacerbation via autophagic flux blockade-mediated ammonia death pathway.

Journal of advanced research
2025

Interplay between age, APOE Ɛ4 and the metabolome in plasma and brain in Alzheimer's disease.

Translational psychiatry
2025

Kmo restricts Salmonella in a whole organism infection model by promoting macrophage lysosomal acidification through kainate receptor antagonism.

PLoS pathogens
2026

Black carp Nup93 negatively regulates IRF3- and IRF7-mediated antiviral immune response.

Journal of immunology (Baltimore, Md. : 1950)
2025

TXNIP mediates LAT1/SLC7A5 endocytosis to limit amino acid uptake in cells entering quiescence.

The EMBO journal
2025

The Novel MuRF2 Target SNX5 Regulates PKA Activity Through Stabilization of RI-α and Controls Myogenic Differentiation.

Journal of cachexia, sarcopenia and muscle
2026

VPS13C heterozygous loss of function as a modifier for suboptimal response to levodopa in Parkinson's disease.

Parkinsonism & related disorders
2025

Therapeutic strategies in cystinosis: A focus on cysteamine and beyond.

Experimental and molecular pathology
2025

WDFY4 Promotes the Progression of Atherosclerosis by Regulating Ferroptosis Mediated by the LAPTM5/CDC42/mTOR/4EBP1/SLC7A11 Pathway.

Journal of cellular and molecular medicine
2025

Dimethyl malonate preserves brain and neurobehavioral phenotype following neonatal hypoxia-ischemia by inhibiting FTH1-mediated ferritinophagy.

Redox biology
2025

Mycophenolate mofetil inhibits ferroptosis by boosting autophagy to prevent pulmonary fibrosis.

Archives of biochemistry and biophysics
2025

Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.

Journal of cachexia, sarcopenia and muscle
2025

LncRNA-induced lysosomal localization of NHE1 promotes increased lysosomal pH in macrophages leading to atherosclerosis.

The Journal of biological chemistry
2025

Computational prediction of deleterious nonsynonymous SNPs in the CTNS gene: implications for cystinosis.

BMC genomic data
2025

Alterations in the Na+/H+ Exchanger NHE6 and Glutamate Transporters may Influence Purkinje Cell Fate in ARSACS.

Cerebellum (London, England)
2026

Long-term outcomes in nephropathic cystinosis: a review.

Pediatric nephrology (Berlin, Germany)
2025

SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes.

Life science alliance
2025

N-acetyl-l-leucine lowers pS129-synuclein and improves synaptic function in models of Parkinson's disease.

Research square
2025

SLC7A11 is an unconventional H+ transporter in lysosomes.

Cell
2025

Inhibiting SNX14 Alleviates Epileptic Seizures by Regulating GluA2 Degradation via the Lysosomal Pathway.

Molecular neurobiology
2025

Novel mechanism for tubular injury in nephropathic cystinosis.

eLife
2025

Puromycin Proximity Ligation Assay (Puro-PLA) to Assess Local Translation in Axons From Human Neurons.

Bio-protocol
2025

Targeting oxidative stress-induced lipid peroxidation enhances podocyte function in cystinosis.

Journal of translational medicine
2025

Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease.

Journal of cellular physiology
2025

Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease.

Human molecular genetics
2025

Amyloid-β-Driven Synaptic Deficits Are Mediated by Synaptic Removal of GluA3-Containing AMPA Receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2025

Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment.

Journal of cell science
2024

NFκB and JNK pathways mediate metabolic adaptation upon ESCRT-I deficiency.

Cellular and molecular life sciences : CMLS
2024

RNAseq and targeted metabolomics implicate RIC8 in regulation of energy homeostasis, amino acid compartmentation, and asexual development in Neurospora crassa.

mBio
2024

Reconstitution of Rab11-FIP4 Expression Rescues Cellular Homeostasis in Cystinosis.

Molecular and cellular biology
2024

[Lysosomal storage disorders - Fabry disease and Gaucher disease].

Deutsche medizinische Wochenschrift (1946)
2024

KA-mediated excitotoxicity induces neuronal ferroptosis through activation of ferritinophagy.

CNS neuroscience & therapeutics
2024

Enhanced Tumor-Targeted Delivery of Arginine-Rich Peptides via a Positive Feedback Loop Orchestrated by Piezo1/integrin β1 Signaling Axis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function.

HGG advances
2024

ELD607 specifically traffics Orai1 to the lysosome leading to inhibition of store operated calcium entry.

Cell calcium
2024

Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

Long-term effects of luteolin in a mouse model of nephropathic cystinosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2024

Accelerated phase development in a late-onset adolescent Chediak-Higashi syndrome patient caused by compound novel LYST mutations in the setting of SARS-CoV-2 infection.

Blood cells, molecules & diseases
2024

New approaches to the control of chronic inflammatory diseases with a focus on the endolysosomal system of immune cells.

International immunology
2024

Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus.

Acta neuropathologica
2024

The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.

Nature communications
2024

Defective Lamtor5 Leads to Autoimmunity by Deregulating v-ATPase and Lysosomal Acidification.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

A mutation in CCDC91, Homo sapiens coiled-coil domain containing 91 protein, cause autosomal-dominant acrokeratoelastoidosis.

European journal of human genetics : EJHG
2024

Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model.

Cells
2024

S-Adenosyl-l-methionine restores brain mitochondrial membrane fluidity and GSH content improving Niemann-Pick type C disease.

Redox biology
2024

MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis.

American journal of physiology. Renal physiology
2024

The Digestive Vacuole of the Malaria Parasite: A Specialized Lysosome.

Pathogens (Basel, Switzerland)
2024

A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis.

International journal of molecular sciences
2023

Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl-/H+ Exchanger ClC-7.

Biomolecules
2024

Extrarenal complications of cystinosis.

Pediatric nephrology (Berlin, Germany)
2024

Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivity.

Journal of the neurological sciences
2023

Event-related potential (ERP) evidence for visual processing differences in children and adults with cystinosis (CTNS gene mutations).

Orphanet journal of rare diseases
2024

Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.

Journal of inherited metabolic disease
2023

Studies with Human-Induced Pluripotent Stem Cells Reveal That CTNS Mutations Can Alter Renal Proximal Tubule Differentiation.

International journal of molecular sciences
2024

Inhibition of Amino Acids Influx into Proximal Tubular Cells Improves Lysosome Function in Diabetes.

Kidney360
2023

Lysinuric protein intolerance caused by a homozygous SLC7A7 deletion and presented with hyperferritinemia and osteoporosis in two siblings.

Molecular genetics and metabolism reports
2024

A Toxoplasma gondii putative amino acid transporter localizes to the plant-like vacuolar compartment and controls parasite extracellular survival and stage differentiation.

mSphere
2024

Glycine recalibrates iron homeostasis of lens epithelial cells by blocking lysosome-dependent ferritin degradation.

Free radical biology & medicine
2023

Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis.

Scientific reports
2023

Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.

Molecular neurodegeneration
2024

Omic Studies on In Vitro Cystinosis Model: siRNA-Mediated CTNS Gene Silencing in HK-2 Cells.

Laboratory investigation; a journal of technical methods and pathology
2023

L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome.

Cells
2023

Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling.

Nature communications
2023

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Biomaterials
2023

A Toxoplasma gondii putative arginine transporter localizes to the plant-like vacuolar compartment and controls parasite extracellular survival and stage differentiation.

bioRxiv : the preprint server for biology
2023

RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression.

Oncogene
2024

The CTNS-MTORC1 axis couples lysosomal cystine to epithelial cell fate decisions and is a targetable pathway in cystinosis.

Autophagy
2023

ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine.

The Journal of clinical investigation
2023

SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidification.

Cell reports
2023

Transcriptome analysis of Cryptocaryon irritans tomont responding to Bacillus licheniformis treatment.

Fish & shellfish immunology
2023

Posterior Segment Involvement in Infantile Nephropathic Cystinosis - A Review.

Klinische Monatsblatter fur Augenheilkunde
2023

[Cystinosis: From the gene identification to the first gene therapy clinical trial].

Medecine sciences : M/S
2023

Beneficial in vitro effect of N-acetylcysteine and coenzyme Q10 on DNA damage in neurodegenerative Niemann-Pick type C 1 disease: preliminary results.

Naunyn-Schmiedeberg's archives of pharmacology
2023

Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication.

PLoS pathogens
2023

Corneal Manifestation in Patients with Infantile Nephropathic Cystinosis.

Klinische Monatsblatter fur Augenheilkunde
2023

The Pitfall of White Blood Cell Cystine Measurement to Diagnose Juvenile Cystinosis.

International journal of molecular sciences
2023

SLC7A14 imports GABA to lysosomes and impairs hepatic insulin sensitivity via inhibiting mTORC2.

Cell reports
2023

Identification of the target protein and molecular mechanism of honokiol in anti-inflammatory action.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2023

A tyrosine-based YXXΦ motif regulates the degradation of aquaporin-4 via both lysosomal and proteasomal pathways and is functionally inhibited by a 10-amino-acid sequence within its C-terminus.

The FEBS journal
2023

The chaperone-assisted selective autophagy complex dynamics and dysfunctions.

Autophagy
2022

A novel diG motif in ORF3a protein of SARS-Cov-2 for intracellular transport.

Frontiers in cell and developmental biology
2022

Lysosomal positioning regulates Rab10 phosphorylation at LRRK2+ lysosomes.

Proceedings of the National Academy of Sciences of the United States of America
2022

[Pulmonary phenotypes of inborn errors of metabolism].

Revue des maladies respiratoires
2022

Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage.

Proceedings of the National Academy of Sciences of the United States of America
2022

Structure and mechanism of human cystine exporter cystinosin.

Cell
2022

Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins.

Science (New York, N.Y.)
2022

The phagosomal solute transporter SLC15A4 promotes inflammasome activity via mTORC1 signaling and autophagy restraint in dendritic cells.

The EMBO journal
2022

Structural basis for proton coupled cystine transport by cystinosin.

Nature communications
2022

The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics.

The Journal of biological chemistry
2022

Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion.

Nature
2022

Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagy.

Autophagy reports
2022

Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.

Molecular genetics and metabolism
2022

LAMP2A mediates the loading of proteins into endosomes and selects exosomal cargo.

Autophagy
2022

Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.

Orphanet journal of rare diseases
2022

Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis.

American journal of physiology. Renal physiology
2022

Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.

Nutrients
2022

Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis.

Diagnostic pathology
2022

Cystinosis and two rare mutations in CTNS gene: two case reports.

Journal of medical case reports
2022

Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia.

Arteriosclerosis, thrombosis, and vascular biology
2022

Cytokine profile and cholesterol levels in patients with Niemann-Pick type C disease presenting neurological symptoms: in vivo effect of miglustat and in vitro effect of N-acetylcysteine and coenzyme Q10.

Experimental cell research
2023

Mutations in V-ATPase in follicular lymphoma activate autophagic flux creating a targetable dependency.

Autophagy
2022

Arginine-Rich Polymers with Pore-Forming Capability Enable Efficient Intracellular Delivery via Direct Translocation Across Cell Membrane.

Advanced healthcare materials
2022

Slc38a9 Deficiency Induces Apoptosis and Metabolic Dysregulation and Leads to Premature Death in Zebrafish.

International journal of molecular sciences
2023

Clinical and genetic characteristics of Tunisian children with infantile nephropathic cystinosis.

Pediatric nephrology (Berlin, Germany)
2022

ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.

Autophagy
2022

Mutation of SLC7A14 causes auditory neuropathy and retinitis pigmentosa mediated by lysosomal dysfunction.

Science advances
2022

Follicular lymphoma-associated mutations in the V-ATPase chaperone VMA21 activate autophagy creating a targetable dependency.

Autophagy
2022

Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting.

Science (New York, N.Y.)
2022

Autophagy-Related Gene PlATG6a Is Involved in Mycelial Growth, Asexual Reproduction and Tolerance to Salt and Oxidative Stresses in Peronophythora litchii.

International journal of molecular sciences
2022

Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis.

Human molecular genetics
2022

Therapeutic regulation of autophagy in hepatic metabolism.

Acta pharmaceutica Sinica. B
2022

Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.

Cellular oncology (Dordrecht, Netherlands)
2022

Bioengineered Cystinotic Kidney Tubules Recapitulate a Nephropathic Phenotype.

Cells
2022

Schistosome TRPML channels play a role in neuromuscular activity and tegumental integrity.

Biochimie
2021

Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside.

Cells
2022

ER proteins decipher the tubulin code to regulate organelle distribution.

Nature
2021

Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic Cystinosis.

International journal of molecular sciences
2021

Direct Interaction of ATP7B and LC3B Proteins Suggests a Cooperative Role of Copper Transportation and Autophagy.

Cells
2021

Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model.

Molecular genetics and metabolism
2021

Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.

Molecular genetics and metabolism
2021

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease.

Acta pharmaceutica Sinica. B
2022

DYNC1LI2 regulates localization of the chaperone-mediated autophagy receptor LAMP2A and improves cellular homeostasis in cystinosis.

Autophagy
2021

Mitochondrial-derived compartments facilitate cellular adaptation to amino acid stress.

Molecular cell
2021

The amyloid precursor protein is a conserved Wnt receptor.

eLife
2021

Renal and Extra Renal Manifestations in Adult Zebrafish Model of Cystinosis.

International journal of molecular sciences
2021

Use of a neuron-glia genome-scale metabolic reconstruction to model the metabolic consequences of the Arylsulphatase a deficiency through a systems biology approach.

Heliyon
2021

Acetylation turns leucine into a drug by membrane transporter switching.

Scientific reports
2021

Arginine-selective modulation of the lysosomal transporter PQLC2 through a gate-tuning mechanism.

Proceedings of the National Academy of Sciences of the United States of America
2021

The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease.

Molecular genetics & genomic medicine
2021

β-Methylamino-L-alanine-induced protein aggregation in vitro and protection by L-serine.

Amino acids
2021

An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.

Kidney international
2021

Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.

EMBO molecular medicine
2021

Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals.

Science immunology
2021

Metabolomic profiling of single enlarged lysosomes.

Nature methods
2021

Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention.

Frontiers in neuroscience
2021

UDP-GlcNAc-1-Phosphotransferase Is a Clinically Important Regulator of Human and Mouse Hair Pigmentation.

The Journal of investigative dermatology
2021

mTOR controls endoplasmic reticulum-Golgi apparatus trafficking of VSVg in specific cell types.

Cellular & molecular biology letters
2021

Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis.

Trends in molecular medicine
2021

Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the NPC2 Mutations c.58G>T/c.140G>T.

International journal of molecular sciences
2022

How autophagy controls the intestinal epithelial barrier.

Autophagy
2021

PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies.

Molecular cancer therapeutics
2021

Assessing the integrity of auditory processing and sensory memory in adults with cystinosis (CTNS gene mutations).

Orphanet journal of rare diseases
2021

The Atg16l1 gene: characterization of wild type, knock-in, and knock-out phenotypes in rats.

Physiological genomics
2021

Serine metabolism antagonizes antiviral innate immunity by preventing ATP6V0d2-mediated YAP lysosomal degradation.

Cell metabolism
2021

The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44.

Molecular genetics and metabolism
2021

Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course.

American journal of medical genetics. Part A
2021

Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release.

Acta neuropathologica communications
2021

Coxsackievirus B3 targets TFEB to disrupt lysosomal function.

Autophagy
2021

West Syndrome Caused By a Chloride/Proton Exchange-Uncoupling CLCN6 Mutation Related to Autophagic-Lysosomal Dysfunction.

Molecular neurobiology
2021

A Novel Homozygous VPS11 Variant May Cause Generalized Dystonia.

Annals of neurology
2021

Cigarette smoke affects ESCRT-mediated vacuolar activity in Saccharomyces cerevisiae.

Toxicology letters
2020

Application of next generation sequencing in genetic counseling a case of a couple at risk of cystinosis.

BMC medical genetics
2020

Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.

Molecular genetics and metabolism
2020

ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.

Proceedings of the National Academy of Sciences of the United States of America
2020

A Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl-/H+-Exchanger, Causes Early-Onset Neurodegeneration.

American journal of human genetics
2021

Large transient capacitive currents in wild-type lysosomal Cl-/H+ antiporter ClC-7 and residual transport activity in the proton glutamate mutant E312A.

The Journal of general physiology
2020

MFSD12 mediates the import of cysteine into melanosomes and lysosomes.

Nature
2020

The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.

Pathogens & immunity
2021

Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2020

The Protein Translocation Defect of MCT8L291R Is Rescued by Sodium Phenylbutyrate.

European thyroid journal
2020

Sensing Host Arginine Is Essential for Leishmania Parasites' Intracellular Development.

mBio
2020

A polylysine-polyhistidine fusion peptide for lysosome-targeted protein delivery.

Biochemical and biophysical research communications
2021

Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.

Alzheimer's & dementia : the journal of the Alzheimer's Association
2020

Autophagy and its role in regeneration and remodeling within invertebrate.

Cell & bioscience
2020

Molecular basis for a new bovine model of Niemann-Pick type C disease.

PloS one
2020

Melasolv induces melanosome autophagy to inhibit pigmentation in B16F1 cells.

PloS one
2020

HMGB1 mediates homocysteine-induced endothelial cells pyroptosis via cathepsin V-dependent pathway.

Biochemical and biophysical research communications
2021

Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons.

Molecular neurobiology
2020

Transcriptome analysis indicates dominant effects on ribosome and mitochondrial function of a premature termination codon mutation in the zebrafish gene psen2.

PloS one
2020

Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.

The Journal of biological chemistry
2020

Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin.

Journal of medicinal chemistry
2021

Nephropathic cystinosis: an update on genetic conditioning.

Pediatric nephrology (Berlin, Germany)
2020

Structural Basis of Low-pH-Dependent Lysosomal Cholesterol Egress by NPC1 and NPC2.

Cell
2020

Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Journal of the American Society of Nephrology : JASN
2020

Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells through a Heavy Isotope Pulse/Trace Proteomic Approach.

Cells
2020

TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.

Nature
2020

The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases.

Translational neurodegeneration
2020

Inherited disorders of lysosomal membrane transporters.

Biochimica et biophysica acta. Biomembranes
2020

The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2020

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.

International journal of molecular sciences
2020

Membrane transport proteins in melanosomes: Regulation of ions for pigmentation.

Biochimica et biophysica acta. Biomembranes
2020

Cholesterol Transport in Wild-Type NPC1 and P691S: Molecular Dynamics Simulations Reveal Changes in Dynamical Behavior.

International journal of molecular sciences
2021

The Role of VPS35 in the Pathobiology of Parkinson's Disease.

Cellular and molecular neurobiology
2020

Isoimperatorin (ISO) reduces melanin content in keratinocytes via miR-3619/CSTB and miR-3619/CSTD axes.

Bioscience, biotechnology, and biochemistry
2020

Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.

Bioscience reports
2020

Structural basis for ion selectivity in TMEM175 K+ channels.

eLife
2021

The Warburg Micro Syndrome-associated Rab3GAP-Rab18 module promotes autolysosome maturation through the Vps34 Complex I.

The FEBS journal
2020

The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.

Human genetics
2020

Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.

Journal of the American Society of Nephrology : JASN
2020

HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes.

Cells
2020

Deficiency in the endocytic adaptor proteins PHETA1/2 impairs renal and craniofacial development.

Disease models & mechanisms
2020

High-content imaging and structure-based predictions reveal functional differences between Niemann-Pick C1 variants.

Traffic (Copenhagen, Denmark)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Defeito no transporte lisossomal.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Defeito no transporte lisossomal

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Hematopoietic Stem-Cell Gene Therapy for Cystinosis.
    The New England journal of medicine· 2026· PMID 41707137mais citado
  2. Calretinin Contributes to Trigeminal Neuropathic Pain Downstream of Cavα2δ1.
    ACS chemical neuroscience· 2026· PMID 41582555mais citado
  3. Homocysteine disrupts lysosomal function by V-ATPase inhibition.
    The Journal of cell biology· 2026· PMID 41288572mais citado
  4. N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.
    The Journal of clinical investigation· 2026· PMID 41766663mais citado
  5. Chronic stress-induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis.
    The Journal of clinical investigation· 2026· PMID 41329521mais citado
  6. Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment.
    J Cell Sci· 2025· PMID 39584231recente
  7. ELD607 specifically traffics Orai1 to the lysosome leading to inhibition of store operated calcium entry.
    Cell Calcium· 2024· PMID 39191091recente
  8. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.
    J Inherit Metab Dis· 2024· PMID 38069516recente
  9. Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins.
    Science· 2022· PMID 36074822recente
  10. Structural basis for proton coupled cystine transport by cystinosin.
    Nat Commun· 2022· PMID 35977944recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79207(Orphanet)
  2. MONDO:0019246(MONDO)
  3. GARD:18974(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55788565(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Defeito no transporte lisossomal
Compêndio · Raras BR

Defeito no transporte lisossomal

ORPHA:79207 · MONDO:0019246
Medicamentos
1 registrados
MedGen
UMLS
C5681276
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades